Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: July 2, 2026
Context: The filing announces an update to a coordinated share buyback programme initiated in February 2026. The Company serves nearly 600 million consumers across 31 countries and is listed on multiple exchanges including Nasdaq, the London Stock Exchange, and Euronext Amsterdam.
Key Financial Metrics and Capital Allocation
This filing focuses on capital return rather than operational financial performance. No revenue, profit, cash flow, or margin data is provided in this document.
- Total Buyback Programme Size: Up to €1 billion.
- First Tranche Status: Completed on April 24, 2026 (Aggregate amount: up to €500 million).
- Second Tranche Size: Up to €500 million.
- Second Tranche Allocation: Up to €130 million designated for London Trading Venues; the remainder for US Trading Venues.
- Maximum Shares for Second Tranche: 42,289,442 ordinary shares.
- Share Treatment: All repurchased shares will be cancelled.
Material Changes and Programme Execution
The primary material change is the commencement of the second and final tranche of the share buyback programme.
- Commencement Date: Expected to begin on July 6, 2026.
- Expected Duration: From July 6, 2026, up to and including December 18, 2026 (subject to earlier completion).
- Execution Method: The Company has entered into arrangements with Goldman Sachs & Co. LLC and Goldman Sachs International (GS) to act as riskless principal. Purchases will be made independently of the Company within agreed parameters.
- Regulatory Compliance: The programme adheres to authorities granted at the 2026 Annual General Meeting, the UK Market Abuse Regulation, UK Listing Rules, and applicable US federal securities laws.
Guidance, Outlook, and Risks
Outlook: If executed in full, the Company expects to return approximately €1 billion to shareholders under the total programme. The filing contains forward-looking statements regarding the completion of the buyback and its impact on share capital.
Risks and Contingencies: The document includes a cautionary note stating that actual results may differ materially from projections due to various risks. Specific risk factors are referenced in the Company's 2025 Annual Report on Form 20-F (filed March 13, 2026). The filing explicitly states it does not constitute an offer or invitation to purchase securities.
Investor Verification Checklist
- Verify the completion status and exact amount spent on the first tranche (up to €500 million) in subsequent filings.
- Monitor the actual execution volume and timing of the second tranche against the expected window (July 6 – December 18, 2026).
- Review the 2025 Annual Report on Form 20-F for detailed risk factors referenced in this filing.
- Confirm the impact of share cancellations on the Company's issued share capital and earnings per share in future quarterly reports.
- Check for any updates regarding the Goldman Sachs riskless principal arrangement if market conditions change.